Evidence map›Paper›PMID 31605668›Full record

ArticleThe FEBS journal2020

Structure of the Cannabis sativa olivetol-producing enzyme reveals cyclization plasticity in type III polyketide synthases.

Lewis J Kearsey, Nicole Prandi, Vijaykumar Karuppiah, Cunyu Yan, David Leys, Helen Toogood, Eriko Takano, Nigel S Scrutton

Open access · hybridAbstract read
In one paragraph

Article in The FEBS journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Understanding metabolic diversification in plants: branchpoints in the evolution of specialized metabolism.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Biosynthesis of Nature-Inspired Unnatural Cannabinoids.Molecules (Basel, Switzerland) · 2021
    Review
  14. The biosynthesis of the cannabinoids.Journal of cannabis research · 2021
    Review
  15. Anti-Inflammatory Potentials of the n-Hexane Fraction ofJournal of inflammation research · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lewis J KearseyManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Nicole PrandiManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Vijaykumar KaruppiahManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Cunyu YanBBSRC/EPSRC Synthetic Biology Research Centre SYNBIOCHEM, The University of Manchester, UK.
David LeysManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Helen ToogoodManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Eriko TakanoManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.
Nigel S ScruttonManchester Institute of Biotechnology and School of Chemistry, The University of Manchester, UK.ORCID 0000-0002-4182-3500
University of Manchester · GBEngineering and Physical Sciences Research Council · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M017702/1Biotechnology and Biological Sciences Research Council BB/R505894/1Biotechnology and Biological Sciences Research Council EP/S01778X/1
6 · The paper itself

Abstract

In the native pathway to therapeutic cannabinoid biosynthesis in Cannabis sativa, the three-step production of a key intermediate, olivetolic acid, is catalysed by the enzymes tetraketide synthase (TKS; linear tetraketide intermediate production in two stages) and olivetolic acid cyclase (OAC; final C2 → C7 aldol condensation). In the absence of OAC, a nonenzymatic C2 → C7 decarboxylative aldol condensation of the tetraketide intermediate occurs forming olivetol. TKS is a type III polyketide synthase, and the question arises why it is unable to form olivetolic acid directly, but instead forms this unwanted side product. We determined the TKS, CoA complex structure, and performed structurally guided mutagenesis studies to identify potential residues responsible for cyclization pathway discrimination in type III polyketide synthases. Prior studies suggested an 'aldol switch' is necessary to allow linear tetraketide intermediate release prior to cyclization, thereby enabling subsequent olivetolic acid production by OAC. However, our studies do not support the presence of a universal or predictable 'aldol switch' consensus sequence. Instead, we propose the mode of ordered active site water activation between type III polyketide synthases catalysing different cyclization mechanisms is subtle and homologue-specific. Our work indicates that subtle structural variations between homologous enzymes can have a major mechanistic impact on the catalytic outcome. This highlights the importance of embedding high-resolution structural analysis of multiple enzyme homologues with classical site-directed mutagenesis studies when investigating highly similar enzymes with different mechanistic pathway outcomes. ENZYMES: TKS, EC 2.3.1.206; OAC, EC 4.4.1.26; chalcone synthase, EC 2.3.1.74; stilbene synthase, EC 2.3.1.95; 2-PS, EC 2.3.1.-. ACCESSION NUMBERS: The atomic coordinates and structure factors for the crystal structure of TKS have been deposited in the Protein Data Bank with accession number 6GW3.

Indexed as

CannabisCyclizationModels, MolecularPolyketide SynthasesProtein ConformationResorcinolsolivetolPolyketide SynthasesResorcinolscannabinoid pathwayolivetolic acidolivetol synthasestructure-guided mutagenesistype III polyketide synthase

Identifiers

PMID31605668
PMCPMC7217186
OpenAlexW2979320654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.